Dr. Sindhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16233 Sylvester Rd SW
Ste 110
Burien, WA 98166Phone+1 206-439-5577
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2013 - 2016
Rochester General HospitalResidency, Internal Medicine, 2009 - 2012
College of Osteopathic Medicine of the PacificClass of 2009
Certifications & Licensure
WA State License 2019 - 2025
AZ State License 2016 - 2021
CA State License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Publications & Presentations
PubMed
- 57 citationsAngiosarcoma treated successfully with anti-PD-1 therapy - a case report.Simran K Sindhu, Lana H. Gimber, Lee D. Cranmer, Ali McBride, Andrew S. Kraft
Journal for Immunotherapy of Cancer. 2017-07-18 - 38 citationsCurrent Concepts in Chemotherapy for Head and Neck Cancer.Simran K Sindhu, Julie E. Bauman
Oral and Maxillofacial Surgery Clinics of North America. 2019-02-01 - 5 citationsNeoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 diseaseJames E. Han, Sun K. Yi, Steven J. Wang, Audrey B. Erman, Shethal Bearelly
Head & Neck. 2019-09-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
